We are Powered by Expertise, and driven by innovation.
Investment Opportunities with ZLPP
Investment
Opportunity
Dynamics of the Pharmaceutical Market
- 2023 Revenue Projections: US$1,163.00bn.
- Growth Forecast (2023–2027): 1. Annual growth rate (CAGR): 5.39%.
- United States Revenue: Expected to generate US$624.10bn in 2023, leading the global market.
2. Projected market volume by 2027: US$1,435.00bn.
- Serviceable Addressable Market (SAM):
- 2023 estimate: US$14.36bn.
- Growth rate (CAGR 2023–2027): 3.35%.
- Projected market volume by 2027: US$16.38bn.
- Market Size Projections:
- 2024 estimate: USD 196.46 million.
- 2029 estimate: USD 240.87 million.
- Growth rate (CAGR 2024–2029): 4.30%.
- Expansion Factors:
- Ageing population: Estimated at 3 million aged 65+ in 2022 (United Nations Population Fund Report).
- Rising rates of chronic diseases such as cardiovascular disease, cancer, and gastrointestinal disorders. Key Trend: Increased demand for drugs due to demographic shifts.
- Growing demand for effective and novel therapeutics driven by:
-
1.An ageing population.
2. Rising prevalence of chronic conditions.
Investment Benefits
Empowering innovation through access to a highly skilled and specialized workforce.
Lucrative Investment Opportunities
Reduced costs in manufacturing medicines and health products ensure maximized profit margins. Being part of this state-of-the-art pharmaceutical park guarantees long-term profitability and attractive returns on investment.
Favorable Government Support
The Zimbabwean government is committed to advancing the pharmaceutical sector and attracting investments. Investors benefit from tax breaks, tailored incentives, and supportive programs that foster industry growth.
Supply Chain Sustainability
Ensure the security and sustainability of medicine manufacturing chains with reduced vulnerabilities. The park creates a resilient supply system to withstand external shocks and unexpected challenges.
Collaborative Business Environment:
The park fosters collaboration among investors, industry professionals, and stakeholders. This ecosystem enables networking, knowledge sharing, and partnerships, leveraging collective expertise and resources.
Export Potential
With the African Continental Free Trade Area (AfCFTA) now operational, investors gain expanded export opportunities and increased access to a broad market across the African continent.
Sustainable and Resilient Supply Chain
The park establishes a reliable, resilient supply chain for medicines, reducing import reliance. It ensures a steady supply of high-quality pharmaceuticals while mitigating risks from market fluctuations.
Regulatory Compliance
Designed to meet international pharmaceutical standards, the park ensures compliance. Investors operate within a regulated environment, adhering to global quality and safety requirements.
Access to Skilled Workforce
The park provides access to a pool of highly trained professionals in pharmaceuticals and life sciences. Investors can leverage local talent and workforce development programs to drive innovation and operational excellence.
Who Can
Invest
- Already existing pharmaceutical manufacturers looking to lower their costs of production
- Already existing pharmaceutical manufacturing companies wishing to be WHO GMP compliant
- New companies looking for a safe and convenient operational base
- Importers ready to go into pharmaceutical manufacturing
- API manufacturers
- Food and beverage companies looking for an expansion base
- Pharmaceutical Manufacturers looking to leverage on FT and EPZ status
- Agro Allied companies
Invest in the Future of Healthcare
The pharmaceutical sector is growing at an impressive rate, driven by rising global healthcare needs and groundbreaking innovations. With opportunities spanning across Africa and beyond, now is the time to make your investment count. Partner with us and grow your wealth while driving global health solutions.